NCT01000428View on ClinicalTrials.gov

The Role of Positron Emission Tomography (PET) During Erlotinib Treatment for Non-small Cell Lung Cancer

UnknownOBSERVATIONAL
Enrollment

34

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

May 31, 2010

Study Completion Date

December 31, 2011

Conditions
ErlotinibLung Cancer
Trial Locations (1)

Unknown

RECRUITING

Asan Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

Asan Medical Center

OTHER